-
501
-
502
Vitamin D on the susceptibility of gestational diabetes mellitus: a mini-review
Published 2025-02-01Subjects: Get full text
Article -
503
Effects of Silybum marianum Extract on High-Fat Diet Induced Metabolic Disorders in Rats
Published 2016-03-01Subjects: Get full text
Article -
504
-
505
The Hormonal dysregulation and its consequences in Obese Women - overview
Published 2025-01-01Subjects: Get full text
Article -
506
The Influence of Concurrent Autoimmune Thyroiditis on the Cardiometabolic Consequences of Cabergoline in Postmenopausal Women
Published 2025-01-01Subjects: “…insulin sensitivity…”
Get full text
Article -
507
The relationship between anxiety and cardiometabolic risk factors in adolescents with obesity: propensity scores
Published 2025-02-01Subjects: Get full text
Article -
508
Prevalence of metabolic syndrome and its risk factors among the government bank’s employees of district Bijnor, Uttar Pradesh: A cross-sectional study
Published 2024-12-01Subjects: “…insulin resistance…”
Get full text
Article -
509
The application of procyanidins in diabetes and its complications: a review of preclinical studies
Published 2025-02-01Subjects: Get full text
Article -
510
The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat
Published 2013-01-01“…At basal insulin levels, tesaglitazar failed to lower HGO or compared to obese controls. …”
Get full text
Article -
511
High-Salt Intake Ameliorates Hyperglycemia and Insulin Resistance in WBN/Kob-Leprfa/fa Rats: A New Model of Type 2 Diabetes Mellitus
Published 2018-01-01“…The present study demonstrated that HS intake ameliorated hyperglycemia and insulin resistance in WBKDF rats, which may be due to increased plasma levels of adiponectin.…”
Get full text
Article -
512
-
513
-
514
Tangduqing Granules Attenuate Insulin Resistance and Abnormal Lipid Metabolism through the Coordinated Regulation of PPARγ and DGAT2 in Type 2 Diabetic Rats
Published 2019-01-01“…Insulin resistance (IR) is a vital hallmark of type 2 diabetes mellitus, which is characterized by an impaired ability of insulin to promote glucose uptake and utilization. …”
Get full text
Article -
515
The Relationship of Metabolic Syndrome Traits with Beta-Cell Function and Insulin Sensitivity by Oral Minimal Model Assessment in South Asian and European Families Residing in the Netherlands
Published 2016-01-01“…South Asians without MetS were more insulin resistant than Europeans without MetS (P=0.033). …”
Get full text
Article -
516
Alpha-Lipoic Acid Attenuates Cerebral Ischemia and Reperfusion Injury via Insulin Receptor and PI3K/Akt-Dependent Inhibition of NADPH Oxidase
Published 2015-01-01“…In conclusion, ALA attenuates cerebral ischemia and reperfusion injury via insulin receptor and PI3K/Akt-dependent inhibition of NADPH oxidase.…”
Get full text
Article -
517
Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes
Published 2021-01-01“…This study investigated the relationship between body fat percentage and time in range (TIR) assessed by continuous glucose monitoring (CGM) during short-term continuous subcutaneous insulin infusion (CSII) therapy in T2DM patients. …”
Get full text
Article -
518
A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes
Published 2019-03-01“…**Objective:** This prospective pragmatic clinical trial evaluated V-Go, a wearable insulin delivery device, compared with standard treatment optimization (STO) among insulin-treated patients with T2DM in a realworld, community-based practice setting. …”
Get full text
Article -
519
-
520
Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin
Published 2020-01-01“…Several clinical trials have addressed the therapeutic strategy of adding dipeptidyl peptidase 4 (DPP-4) inhibitors to the treatment of type 2 diabetes mellitus (DM) inadequately controlled by insulin therapy. However, there is a high degree of heterogeneity in these studies, and the cause of which has not been identified. …”
Get full text
Article